Business
Is Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) Hit More of the Losses Given A -186.59% Dip From High?
During the last session, Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)’s traded shares were 0.33 million, with the beta value of the company hitting -0.43. At the